If TEMRA cells contain a high proportion of HIV-specific effector T cells, this would overcome a potential Achilles' heel of the immune response during HIV-1 infection; that is, CD4+ T cells that are activated by HIV-1 antigens themselves become highly susceptible targets for the virus [31]. The gene discussed is CD4; the disease is HIV-1 infection.